The Defense Health Agency seeks extramural medical research benefiting military and civilian care through September 30, 2027, with required pre-applications and invited full applications.
Funder: Dept. of the Army — USAMRAA
Due Dates: September 30, 2027, 11:59 p.m. Eastern Time (Closing date; rolling submissions)
Funding Amounts: No specified funding limit; assistance agreements up to 4 years, contracts up to 5 years
Summary: Supports extramural medical research advancing knowledge and solutions for military and civilian medical practice.
Key Information: A pre-application through eBRAP is required; full applications are accepted only by invitation.
The Defense Health Agency (DHA) Science and Technology program solicits extramural medical research through this five-year Broad Agency Announcement (BAA). It supports scientific study and experimentation that advance knowledge or the state of the art, rather than focusing on developing a specific system or hardware solution. Supported work includes basic and applied research, advanced technology development, preclinical and clinical research, and clinical trials. Advanced component development and prototypes may qualify under certain conditions.
Research priorities address military medical capability gaps and operationally relevant prevention, stabilization, treatment, and recovery. The eight research areas are military infectious diseases, combat casualty care, traumatic brain injury, psychological health, sensory systems, musculoskeletal injury, environmental exposures, and directed energy/radiation health. Funded research is intended to benefit and inform both military and civilian medical practice.